This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.83% per year. These returns cover a period from January 1, 1988 through January 5, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
biofuels: Archive
Bull of the Day: Bloom Energy (BE)
by Kevin Cook
Clean fuel-cell tech has a big growth market with the AI buildout and Bloom is already prospering
BEPositive Net Change ORCLPositive Net Change TSLAPositive Net Change METANegative Net Change OKLOPositive Net Change
alt-energy artificial-intelligence batteries biofuels energy utilities
SRPT Stock Soars on Unveiling New Restructuring Plan, Pipeline Pivots
by Zacks Equity Research
Sarepta's shares jump after unveiling a major restructuring plan to cut costs. The company shifts focus to siRNA and reprioritizes its pipeline.
RHHBYPositive Net Change SRPTPositive Net Change ARWRNegative Net Change
biofuels gene-editing gene-therapy medical pharmaceuticals
3 Momentum Anomaly Picks as Markets Wobble on Fresh Tariff Salvo
by Supriyo Bose
URBN, RGLD and KGS are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.
URBNPositive Net Change RGLDPositive Net Change KGSPositive Net Change
basic-materials biofuels retail
Buy 5 High ROE Stocks as Markets Break Tariff-Induced Losing Streak
by Supriyo Bose
CBOE, AGNC, JAZZ, AES and CNSWF are some of the stocks with high ROE to profit from as markets expect the tariff war to end soon.
AGNCPositive Net Change AESPositive Net Change CBOENegative Net Change JAZZPositive Net Change CNSWFNegative Net Change
biofuels biotechnology fin-tech finance reit tech-stocks
3 Momentum Anomaly Stocks to Buy as Markets Rise on Tariff Pause
by Supriyo Bose
JWN, EXE and CME are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.
CMEPositive Net Change EXEPositive Net Change
biofuels finance retail
5 High ROE Stocks to Buy as Markets Dip Despite Rate Cut Hopes
by Supriyo Bose
MPLX, LDOS, JAZZ, FTNT and PPC are some of the stocks with high ROE to profit from as markets falter on tariff concerns.
JAZZPositive Net Change PPCNegative Net Change FTNTPositive Net Change MPLXNegative Net Change LDOSPositive Net Change
aerospace biofuels biotechnology consumer-discretionary tech-stocks
PCRX Stock Rises 11% on Upbeat Q4 Preliminary Product Sales
by Zacks Equity Research
Pacira stock gains 11% on better-than-expected preliminary Q4 sales figures. It also shares a strategic growth plan to drive innovation and value creation by 2030.
HALOPositive Net Change PCRXPositive Net Change CTMXPositive Net Change CSTLPositive Net Change
biofuels biotechnology medical pharmaceuticals
Buy 5 Genomics & Synthetic Biology Stocks Likely to Soar in Short Term
by Nalak Das
These five geonomics and synthetic biology stocks are likely to soar in the short-term. They Are: CRSP, IMCR, GLUE, RIGL, CSTL.
RIGLPositive Net Change CRSPPositive Net Change CSTLPositive Net Change IMCRPositive Net Change GLUEPositive Net Change
biofuels biotechnology
2 Momentum Anomaly Picks as Solid Earnings Boost Markets
by Supriyo Bose
CRS and AROC are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.
CRSPositive Net Change AROCPositive Net Change
basic-materials biofuels
Buy 5 High ROE Stocks as Low Inflation Data Steadies Market
by Supriyo Bose
Upbound Group (UPBD), AES Corporation (AES), Arch Capital (ACGL), PulteGroup (PHM) and Banco de Chile (BCH) are some of the stocks with high ROE to profit as markets inch closer to all-time highs reached in mid-July.
PHMPositive Net Change AESPositive Net Change BCHNegative Net Change ACGLNegative Net Change UPBDPositive Net Change
biofuels business-services construction fin-tech finance